Ataxia telangiectasia overview: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Ataxia telangiectesia}} {{CMG}} == Overview == '''Ataxia-telangiectasia''' (AT) ('''Boder-Sedgwick syndrome'''<ref>{{WhoNamedIt|synd|3567}}</ref> or '''Louis-B...") |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Ataxia | {{Ataxia telangiectasia}} | ||
{{CMG}} | {{CMG}} |
Revision as of 19:42, 21 August 2012
Ataxia telangiectasia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Ataxia telangiectasia overview On the Web |
American Roentgen Ray Society Images of Ataxia telangiectasia overview |
Risk calculators and risk factors for Ataxia telangiectasia overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Ataxia-telangiectasia (AT) (Boder-Sedgwick syndrome[1] or Louis-Bar syndrome) is a primary immunodeficiency disorder that occurs in an estimated incidence of 1 in 40,000 to 1 in 300,000 births (Lederman, 2000).
It is associated with a defect in T-cells.[2]
References
- ↑ Template:WhoNamedIt
- ↑ "Ataxia-Telangiectasia: Immunodeficiency Disorders: Merck Manual Professional". Retrieved 2008-03-01.